Comment by alephnerd
4 months ago
Sure in finance (and even then it has been overshadowed by London, Frankfurt, and Amsterdam by the 2000s), but not really in innovation industries like the Life Sciences - which has historically been Switzerland's strongest niche and a major reason for Switzerland's modern success.
This was largely due to the success of Biogen in the 1980s which helped link American biopharma IP with the Swiss ecosystem along with a fairly permissive PR program for skilled foreign nationals.
Edit: cannot reply
> Roche and Lanza
Roche and Lanza would have remained CDMOs if it wasn't for Biogen bringing an entire generation of Harvard and MIT Biopharma researchers to Switzerland in the 1980s and helped build an ecosystem for therapeutics and biopharma R&D.
Much of Roche's biopharma and therapeutics leadership and IP is derived from Biogen alumni.
Some say Swiss was always "naturally lucky" due its location in the "blue banana" region: https://en.wikipedia.org/wiki/Blue_Banana
Biogen? Seriously?
Swiss pharma was driven by Roche and Lonza, which are much older than Biogen.